MedTrace Logo

A Retrospective Non-interventional Study to Evaluate the Use of Seroquel Extended Release (XR) and Immediate Release (IR) in the Clinical Practice of Inpatients With Schizophrenia

NCT01214135 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2011-01-11

No results posted yet for this study

Summary

The primary objective of this non-interventional study is to investigate how Seroquel XR and Seroquel IR are used in the clinical practice of inpatients with schizophrenia. This will be done by a retrospective review of medical records to evaluate patients treated with Seroquel XR or Seroquel IR as primary antipsychotic treatment.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Dr Eva Dencker Vansvik, MD · AstraZeneca

  • Dr Lars Eriksson, MD · Rättspsykiatriska Vårdkedjan, Hisings-Backa, Sweden

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01214135 on ClinicalTrials.gov